TY - JOUR
T1 - Acute Mountain Sickness
AU - Johnson, T. Scott
AU - Rock, Paul B.
PY - 1988/9/29
Y1 - 1988/9/29
N2 - THE majority of persons who ascend rapidly to terrestrial elevations higher than approximately 2500 m (8200 ft) undergo an unpleasant period of acclimatization. During this time, they have a variety of symptoms, the most prominent of which are headache, nausea, vomiting, and insomnia, that are collectively referred to as acute mountain sickness.1 2 3 This paper reviews current concepts of the pathogenesis and treatment of this disorder. Factors that influence susceptibility to this condition will be discussed. Acute mountain sickness is part of a continuum of diseases related to ascension to high altitudes4 that includes the infrequent life-threatening conditions high-altitude pulmonary edema.
AB - THE majority of persons who ascend rapidly to terrestrial elevations higher than approximately 2500 m (8200 ft) undergo an unpleasant period of acclimatization. During this time, they have a variety of symptoms, the most prominent of which are headache, nausea, vomiting, and insomnia, that are collectively referred to as acute mountain sickness.1 2 3 This paper reviews current concepts of the pathogenesis and treatment of this disorder. Factors that influence susceptibility to this condition will be discussed. Acute mountain sickness is part of a continuum of diseases related to ascension to high altitudes4 that includes the infrequent life-threatening conditions high-altitude pulmonary edema.
UR - http://www.scopus.com/inward/record.url?scp=0023681510&partnerID=8YFLogxK
U2 - 10.1056/NEJM198809293191306
DO - 10.1056/NEJM198809293191306
M3 - Review article
C2 - 3045554
AN - SCOPUS:0023681510
SN - 0028-4793
VL - 319
SP - 841
EP - 845
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 13
ER -